Scorecard from the Commonwealth Fund notes stark gaps between best and worst performing states
NATIONAL REPORTS-When it comes to healthcare, the gap between top- and bottom-performing states is widening, according to the latest state scorecard by the Commonwealth Fund Commission on a High Performance Health System. The scorecard found wide and growing disparity between the states in cost, quality, access and outcomes.
In general, states that led in the way on the scorecard two years ago continued to lead, often setting new benchmarks. Vermont, which ranked fourth in 2007, now has the top ranking, followed by Hawaii, Iowa, Minnesota and Maine. Mississippi again ranked the worst. Oklahoma, Arkansas, Texas and Nevada, which placed in the bottom five in 2007, continued to bring up the rear.
MEASURING THE GAP
Overall, the report, which ranks states based on 38 indicators, found that while health insurance coverage for adults declined in a majority of states since the release of the 2007 scorecard, most states made gains in health coverage for children due to federal and state support for the Children's Health Insurance Program (CHIP). The report also noted that a national push for public reporting of outcomes data has led to dramatic improvements in some measures of quality of care in hospitals and nursing homes.
"The main takeaway of this report is when we take action at the national level we can succeed," said Commonwealth President Karen Davis, citing the report and the need for comprehensive healthcare reform at a recent press conference. "The states can't go it alone."
That's particularly true for bottom-tier states which lack the tax base to close health gaps without federal participation, according to Joel Cantor, director of the Center for State Health Policy at Rutgers University and one of the report's authors.
In terms of performance, the report finds that several states in the Upper Midwest-Iowa, Minnesota, Nebraska, North Dakota and South Dakota-were all providing high quality care at lower cost.
If all states could reach the level achieved by the top-performing states, 29 million more people would have health insurance, nearly 78,000 lives could be saved by delivering timely, effective care and the nation would realize a $5 billion annual savings by avoiding preventable hospital admissions and readmissions for vulnerable elderly and disabled residents.
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
Opzelura May Reduce Need for Other Treatments in Atopic Dermatitis | AAD 2025
March 11th 2025Patients with atopic dermatitis who had not received biologics prior to treatment with Opzelura were able to avoid biologics during the 12 months after treatment with the topical nonsteroidal, finds study at American Academy of Dermatology Association annual meeting.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen
Supporting Patients with Type 1 Diabetes Through Education, Technology and Transparency
March 10th 2025Arti Masturzo, M.D., chief medical officer of CCS, spoke with MHE in this third part of a video series to share how CCS helps patients with type 1 diabetes effectively use glucose monitors and insulin pumps by providing clear guidance and troubleshooting support, recognizing that even minor errors in management can have significant health consequences.
Read More
Melanoma Treatment Advances Now Crossing into Other Skin Cancers
March 10th 2025Deborah S. Sarnoff, M.D., talks about the recent breakthrough treatments that are paving the way to treat patients with advanced basal cell carcinoma, squamous cell carcinoma and Merkel cell carcinoma, which is a rare and aggressive type of skin cancer.
Read More